Follow
Andrew Lawrence Mason
Title
Cited by
Cited by
Year
Association of diabetes mellitus and chronic hepatitis C virus infection
AL Mason, JY Lau, N Hoang, KP Qian, GJ Alexander, L Xu, L Guo, ...
Hepatology 29 (2), 328-333, 1999
9141999
A placebo-controlled trial of obeticholic acid in primary biliary cholangitis
F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ...
New England Journal of Medicine 375 (7), 631-643, 2016
8582016
Characterization of the gut microbiome using 16S or shotgun metagenomics
J Jovel, J Patterson, W Wang, N Hotte, S O'Keefe, T Mitchel, T Perry, ...
Frontiers in microbiology 7, 459, 2016
6962016
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants
GM Hirschfield, X Liu, C Xu, Y Lu, G Xie, Y Lu, X Gu, EJ Walker, K Jing, ...
New England Journal of Medicine 360 (24), 2544-2555, 2009
6582009
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid
GM Hirschfield, A Mason, V Luketic, K Lindor, SC Gordon, M Mayo, ...
Gastroenterology 148 (4), 751-761. e8, 2015
5932015
The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis
Z Li, LB Agellon, TM Allen, M Umeda, L Jewell, A Mason, DE Vance
Cell metabolism 3 (5), 321-331, 2006
5732006
GP73, a novel Golgi-localized protein upregulated by viral infection
RD Kladney, GA Bulla, L Guo, AL Mason, AE Tollefson, DJ Simon, ...
Gene 249 (1-2), 53-65, 2000
5142000
Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C
RH Wiesner, M Sorrell, F Villamil, V Balan, M Berenguer, RS Brown, ...
Liver Transplantation 9 (11), S1-S9, 2003
4942003
The human gut microbiome in health and disease
J Jovel, LA Dieleman, D Kao, AL Mason, E Wine
Metagenomics, 197-213, 2018
4692018
Back to basics: What is the demographic dividend?
R Lee, A Mason
Finance & development 43 (003), 2006
4362006
Effect of oral capsule–vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial
D Kao, B Roach, M Silva, P Beck, K Rioux, GG Kaplan, HJ Chang, ...
Jama 318 (20), 1985-1993, 2017
4352017
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis
X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ...
Nature genetics 42 (8), 658-660, 2010
4342010
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study
WJ Lammers, HR Van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ...
Gastroenterology 147 (6), 1338-1349. e5, 2014
4222014
Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
S Nair, A Mason, J Eason, G Loss, RP Perrillo
Hepatology 36 (1), 150-155, 2002
3962002
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ...
Nature genetics 45 (6), 670-675, 2013
3752013
Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy
WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ...
Gastroenterology 149 (7), 1804-1812. e4, 2015
3622015
Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis
TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ...
Gastroenterology 152 (8), 1975-1984. e8, 2017
3282017
Sirolimus‐based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma
NM Kneteman, J Oberholzer, M Al Saghier, GA Meeberg, M Blitz, MM Ma, ...
Liver Transplantation 10 (10), 1301-1311, 2004
3222004
Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases
H Armstrong, M Alipour, R Valcheva, M Bording-Jorgensen, J Jovel, ...
Microbiome 7 (1), 1-17, 2019
3122019
Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen
AL Mason, L Xu, L Guo, M Kuhns, RP Perrillo
Hepatology 27 (6), 1736-1742, 1998
2761998
The system can't perform the operation now. Try again later.
Articles 1–20